What one share of TherapeuticsMD holds
TherapeuticsMD is a pharmaceutical royalty company that owns or has rights to trademarks, service marks, or trade names that were previously used in connection with the operation of its business, or are now licensed by another party, including TherapeuticsMD®, vitaMedMD®, BocaGreenMD®, BIJUVA®, and IMVEXXY®, which are protected under applicable intellectual property laws and are the property of the Company.
TherapeuticsMD’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.28 |
|---|---|
| Profit | −$0.02 |
| Cash and investments | $0.79 |
| Book value | $2.34 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2011 | $1.67 | −$10.33 | $0.02 | −$4.00 | — | −$1.03 |
| 2012 | $2.08 | −$19.16 | $0.04 | −$6.99 | — | −$0.72 |
| 2013 | $3.44 | −$11.14 | $0.02 | −$8.16 | — | $18.86 |
| 2014 | $5.02 | −$18.11 | $0.01 | −$15.21 | — | $15.50 |
| 2015 | $5.82 | −$24.56 | $0.05 | −$22.87 | — | $17.72 |
| 2016 | $4.94 | −$22.92 | $0.10 | −$17.73 | — | $32.41 |
| 2017 | $4.08 | −$18.71 | $0.01 | −$18.54 | — | $30.01 |
| 2018 | $3.58 | −$29.47 | $0.05 | −$23.78 | — | $20.28 |
| 2019 | $10.08 | −$35.75 | $0.50 | −$34.13 | — | $1.70 |
| 2020 | $11.77 | −$33.29 | $0.04 | −$28.96 | — | −$20.68 |
| 2021 | — | −$21.66 | $0.00 | −$17.93 | — | −$10.89 |
| 2022 | — | $11.96 | — | — | — | $3.70 |
| 2023 | $0.12 | −$0.98 | — | — | — | $2.54 |
| 2024 | $0.15 | −$0.19 | — | — | — | $2.37 |
| 2025 | $0.26 | −$0.05 | — | — | — | $2.32 |
Common questions about TherapeuticsMD
How much does one share of TherapeuticsMD earn?
Over the last 12 months, TherapeuticsMD lost $0.02 for each share on $0.28 of sales.
Does TherapeuticsMD pay a dividend?
TherapeuticsMD didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is TherapeuticsMD’s book value per share?
TherapeuticsMD’s book value is $2.34 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of TherapeuticsMD have?
Each share of TherapeuticsMD has $0.79 of cash and investments, as of June 30, 2026.
Has TherapeuticsMD bought back shares?
TherapeuticsMD’s share count rose about 825% from 2011 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.